Summarized by Masters of Longevity from Longevity Technology.
A preview of a consumer telehealth product focused on using an AI-derived blood test to guide clinician-led personalized aging care. Expect details about the platform’s services, workflow and subscription-based delivery model.
Key Takeaways
- The platform will launch in the United States in October 2026 and operate across all 50 states.
- An AI-generated BloodAge report from routine blood tests will be used quarterly to estimate biological age and track progress.
- Planned services include clinician-guided personalized plans covering GLP-1 therapies, peptides, hormone replacement, and testosterone treatments.
